{"id":"CHEMBL101740","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccccc21","inchiKey":"ODQWQRRAPPTVAG-BOPFTXTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIDOXEPIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cidoxepin","Doxepin trans-form hydrochloride","Doxepin, (z)-"],"crossReferences":{"Wikipedia":["Doxepin"],"drugbank":["DB14750"],"chEBI":["36691"]},"childChemblIds":["CHEMBL1256774"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1082","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"LSQZJLSUYDQPKJ-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOXICILLIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amix 125","Amix 250","Amix 500","Amopen","Amoram","Amoxi-Inject","Amoxi-Tabs","Amoxicillin","Amoxicillin pediatric","Amoxicilline","Amoxident 250","Amoxident 500","Amoxil","Amoxil fiztab","Amoxil sf","Amoxycillin","Amoxymed","Amrit","Aquacil","Biomox","Dedoxil","Dispermox","Flemoxin solutab","Galenamox","Larotid","Moxatag","Polymox","Respillin","Robamox","Sumox","Trimox","Utimox","Vetremox","Wymox","Zoxycil 250","Zoxycil 500"],"synonyms":["Amoxicillin","Amoxicillin (anhydrous)","Amoxicillin (as trihydrate)","Amoxicillin anhydrous","Amoxicillin hydrate","Amoxicillin trihydrate","Amoxicilline","Amoxicillinum trihydricum","Amoxycillin","Amoxyke","Atoksilin","BRL 2333","BRL-2333","Damoxy","Demoksil","Largopen","Moksilin","NSC-277174","Promoxil","Remoxil","Topramoxin"],"crossReferences":{"DailyMed":["amoxicillin"],"PubChem":["144204854","144204855","50124271","855939"],"Wikipedia":["Amoxicillin"],"drugbank":["DB01060"],"chEBI":["2676"]},"childChemblIds":["CHEMBL2105950"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 11 approved and 46 investigational indications."}
{"id":"CHEMBL1095930","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1","inchiKey":"KEJCWVGMRLCZQQ-YJBYXUATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFUROXIME AXETIL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftin","Cefuroxime axetil","Zinnat"],"synonyms":["CCI 15641","CCI-15641","Cefurax","Cefuroxime (as axetil)","Cefuroxime 1-acetoxyethyl ester","Cefuroxime axetil","Cepazine","Cetoxil","Curocef","Elobact","NSC-758677","Novador","Novocef","Oraxim","Zinat"],"crossReferences":{"DailyMed":["cefuroxime%20axetil"],"chEBI":["3516"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 9 approved and 1 investigational indication."}
{"id":"CHEMBL1121","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"IZTQOLKUZKXIRV-YRVFCXMDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SINCALIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kinevac"],"synonyms":["Cck c-terminal octapeptide","Cck-8","Cholecystokinin","Cholecystokinin c-terminal octapeptide","Pancreozymin","SQ 19844","SQ-19844","Sincalide"],"crossReferences":{"DailyMed":["sincalide"],"PubChem":["144206508","144207030"],"Wikipedia":["Sincalide"],"drugbank":["DB09142"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL11359","drugType":"Small molecule","blackBoxWarning":true,"name":"CISPLATIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2068237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cisplatin","Platinol","Platinol-aq"],"synonyms":["CIS-DDP","Cis-diamminedichloroplatinum","Cis-diamminedichloroplatinum ii","Cis-platin","Cis-platinum ii","Cisplatin","Cisplatinum","Fauldiscipla","INT-230-6 COMPONENT CISPLATIN","INT230-6 COMPONENT CISPLATIN","Liplacis","NSC-119875","Peyrone's salt","cis-diamminedichloroplatinum(II)"],"crossReferences":{"DailyMed":["cisplatin"],"DrugCentral":["4392"],"PubChem":["17389100","301178","50105439","557830","90340859"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for neoplasm and cancer and has 173 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1180725","canonicalSmiles":"CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C","inchiKey":"VVWYOYDLCMFIEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANTHELINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Propantheline","Propantheline cation","Propantheline ion"],"crossReferences":{"DailyMed":["propantheline%20bromide"],"PubChem":["11111683","11112101","90340675"],"drugbank":["DB00782"],"chEBI":["8481"]},"childChemblIds":["CHEMBL1240"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["EFO_0010282","MONDO_0004247","EFO_0004253","EFO_1000781"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for peptic ulcer disease and gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL1200686","canonicalSmiles":"CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC","inchiKey":"KASDHRXLYQOAKZ-XDSKOBMDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIMECROLIMUS","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elidel"],"synonyms":["Pimecrolimus","SDZ ASM 981","SDZ ASM-981","SDZ-ASM 981","SDZ-ASM-981"],"crossReferences":{"DailyMed":["pimecrolimus"],"Wikipedia":["Pimecrolimus"],"drugbank":["DB00337"]},"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["MONDO_0026045","EFO_1000906","HP_0000964","EFO_1000764","EFO_1000724","MONDO_0002406","EFO_1001305","EFO_0004208","EFO_0000274","EFO_1000726","EFO_0008517","Orphanet_634"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for atopic eczema and eczema and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200862","canonicalSmiles":"C[C@](N)(Cc1ccc(O)cc1)C(=O)O","inchiKey":"NHTGHBARYWONDQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METYROSINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demser"],"synonyms":["L-588357-0","MK-781","Metirosine","Metyrosine","Racemetirosine, (s)-"],"crossReferences":{"DailyMed":["metyrosine"],"PubChem":["170465112","29215162","50106644","50106645","50106646","90341393"],"Wikipedia":["Metirosine"],"drugbank":["DB00765"],"chEBI":["6912"]},"linkedTargets":{"rows":["ENSG00000180176"],"count":1},"linkedDiseases":{"rows":["EFO_0005407","EFO_0000239","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for adrenal gland pheochromocytoma and hypertension and has 1 investigational indication."}
{"id":"CHEMBL1200953","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"FOGXJPFPZOHSQS-AYVLZSQQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE PROBUTATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pandel"],"synonyms":["Hydrocortisone buteprate","Hydrocortisone butyrate propionate","Hydrocortisone probutat","Hydrocortisone probutate","TS 408","TS-408"],"crossReferences":{"DailyMed":["hydrocortisone%20probutate"],"PubChem":["144206491"],"drugbank":["DB14543"],"chEBI":["31675"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001222","EFO_0005539","EFO_0000685","EFO_0000729","HP_0000989","EFO_1000764","EFO_1001435","EFO_0000701","EFO_0003778","EFO_0001379","EFO_0000274","EFO_1000697","EFO_0002609","EFO_0000311","EFO_0000565","MP_0001845","MONDO_0003937","MONDO_0002471","MONDO_0002406","EFO_0000676","EFO_0000574","MONDO_0004979","EFO_0007141","MONDO_0005178"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 24 approved indications."}
{"id":"CHEMBL1201494","drugType":"Unknown","blackBoxWarning":false,"name":"SODIUM FERRIC GLUCONATE COMPLEX","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferrlecit","Sodium ferric gluconate complex in sucrose"],"synonyms":["Ferric sodium gluconate complex","Sodium ferric gluconate complex"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1201651","drugType":"Protein","blackBoxWarning":true,"name":"PROTAMINE SULFATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prosulf","Protamine Sulphate","Protamine sulfate"],"synonyms":["Novo protamine sulfate","Protamine","Protamine sulfate","Protamine sulphate","Protamines","Protamini sulfas"],"crossReferences":{"DailyMed":["protamine%20sulfate"],"DrugCentral":["5034"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1969. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1205948","canonicalSmiles":"O=C(O)CCCCO","inchiKey":"PHOJOSOUIAQEDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04781"],"chEBI":["45564"]},"childChemblIds":["CHEMBL170082"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231391","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OVRNDRQMDRJTHS-UOLFYFMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-ACETYLMANNOSAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dex-m74","Mannac","N-acetylmannosamine"],"crossReferences":{"Wikipedia":["N-Acetylmannosamine"],"chEBI":["41112"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1232343","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O","inchiKey":"PHTAQVMXYWFMHF-QVPNGJTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232343","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04678"],"chEBI":["42088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232858","canonicalSmiles":"CCCCCCCCCCC[C@@H](O)CC(=O)O","inchiKey":"ATRNZOYKSNPPBF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxymyristic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxymyristic Acid"],"crossReferences":{"drugbank":["DB02767"],"chEBI":["42539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235228","canonicalSmiles":"C=C(OP(=O)(O)O)C(=O)O","inchiKey":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOENOLPYRUVATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxo-Phosphonooxy-Acetic Acid"],"crossReferences":{"drugbank":["DB01819"],"chEBI":["44897"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235491","canonicalSmiles":"Cc1cn([C@H]2C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"CSNCBOPUCJOHLS-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235491","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235900","canonicalSmiles":"CC(=O)[C@@H](N)COCc1ccccc1","inchiKey":"ISLRAQPEXPIKDJ-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-BENZYL-l-SERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02148"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1257030","canonicalSmiles":"O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12","inchiKey":"WDRYRZXSPDWGEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONIDAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doridamina","Lonidamine","NSC-741419","NSC-758419"],"crossReferences":{"PubChem":["11111381","11114165","11532966","124880557","144203732","144209504","170466647","50104921","50104922","85231114","90341155"],"drugbank":["DB06266"],"chEBI":["50138"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1292","canonicalSmiles":"CC(C)/N=c1\\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1","inchiKey":"WDQPAMHFFCXSNU-BGABXYSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFAZIMINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lamprene"],"synonyms":["Chlofazimine","Clofazimine","Clofaziminum","Colfazimine","G 30320","G-30320","NSC-141046"],"crossReferences":{"PubChem":["11112506","121269827"],"Wikipedia":["Clofazimine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for leprosy and has 7 investigational indications."}
{"id":"CHEMBL1354199","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"CXYRUNPLKGGUJF-RAFJPFSSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHSCOPOLAMINE BROMIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376897","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methscopolamine bromide","Pamine","Pamine forte"],"synonyms":["(-)-Scopolamine Methyl Bromide","Epoxytropine tropate methylbromide","Holopon","Hyoscine methobromide","Methscopolamine bromide","Methylscopolamine bromide","N-methylscopolamine bromide","N-methylscopolamine methylsulfate","NSC-120606","Scopolamine methyl bromide","Scopolamine methylbromide"],"crossReferences":{"DailyMed":["methscopolamine%20bromide"],"PubChem":["11532979","144203588","170464623"],"chEBI":["61276"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1396","canonicalSmiles":"c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"JQSHBVHOMNKWFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARENICLINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-526,555","CP-526555","Chantix","Varenicline"],"crossReferences":{"DailyMed":["varenicline%20tartrate"],"PubChem":["174007164"],"drugbank":["DB01273"]},"childChemblIds":["CHEMBL1201135","CHEMBL556954","CHEMBL2358534","CHEMBL2062259"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","MONDO_0005090","Orphanet_98757","EFO_0002610","EFO_0004329","EFO_1000906","EFO_0001645","EFO_0003768","EFO_0000313","EFO_0001071","Orphanet_95","EFO_0000311","EFO_0007191","EFO_0003890","MONDO_0002491","EFO_0006344","MONDO_0005180","MONDO_0008903","MONDO_0004975","MONDO_0004979","EFO_0004701","MONDO_0007079","EFO_0005411","EFO_0005672"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for nicotine dependence and has 20 investigational indications."}
{"id":"CHEMBL1485","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arginine","L-arginine","NSC-206269"],"crossReferences":{"PubChem":["11110746","11113629","170465748","50104526","90341198"],"Wikipedia":["Arginine"],"drugbank":["DB00125"],"chEBI":["16467"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 39 investigational indications."}
{"id":"CHEMBL153984","canonicalSmiles":"CC(=O)c1cc2cccc(OCC(O)CNC(C)C)c2o1","inchiKey":"ZPQPDBIHYCBNIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEFUNOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Befunolol","Befunolol hydrochloride"],"crossReferences":{"Wikipedia":["Befunolol"],"drugbank":["DB09013"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1549","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1","inchiKey":"DLVOSEUFIRPIRM-KAQKJVHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE CYPIONATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortef"],"synonyms":["Hydrocortisone Cypionate","Hydrocortisone cipionate","Hydrocortisone cyclopentylpropionate","Hydrocortisone cypionate","NSC-10721"],"crossReferences":{"PubChem":["75847"],"drugbank":["DB14541"],"chEBI":["5783"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0009552","EFO_0005752","HP_0004798"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for eye inflammation and hemorrhoid."}
{"id":"CHEMBL1587","canonicalSmiles":"CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O","inchiKey":"CYLWJCABXYDINA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYTHIAZIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nephril","Renese"],"synonyms":["NSC-108161","P-2525","Polythiazide"],"crossReferences":{"PubChem":["144206688","170465068"],"Wikipedia":["Polythiazide"],"drugbank":["DB01324"],"chEBI":["8327"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1639","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC","inchiKey":"UXOWGYHJODZGMF-QORCZRPOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALISKIREN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rasilez"],"synonyms":["Aliskiren","SPP-100","SPP100"],"crossReferences":{"DailyMed":["aliskiren%20hemifumarate"],"Wikipedia":["Aliskiren"],"drugbank":["DB09026"],"chEBI":["601027"]},"childChemblIds":["CHEMBL559358","CHEMBL1667","CHEMBL3545059","CHEMBL3508698"],"linkedTargets":{"rows":["ENSG00000143839"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000275","EFO_0000401","EFO_0000373","EFO_0000319","EFO_1001461","EFO_0004194","Orphanet_558","EFO_0000537","EFO_0003914","EFO_0003896","EFO_0000195","MONDO_0001134","MONDO_0021661","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0000612","EFO_0009321","EFO_0000400","MONDO_0005148","EFO_0005672"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1738990","canonicalSmiles":"CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C","inchiKey":"XLMALTXPSGQGBX-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOPROPOXYPHENE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-propoxyphene","L-propoxyphene","Levopropoxyphene","Propoxyphene, (-)-","Propoxyphene, l-"],"crossReferences":{"drugbank":["DB06793"]},"childChemblIds":["CHEMBL1593906"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1739","canonicalSmiles":"COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3.[I-].[I-]","inchiKey":"DIGFQJFCDPKEPF-OIUSMDOTSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"METOCURINE IODIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1259","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metubine iodide"],"synonyms":["Dimethyl tubocurarine iodide","Dimethylchondrocurarine iodide","Dimethyltubocurarinium iodide","Metocurine iodide","NSC-36388"],"crossReferences":{"PubChem":["144206308","170465111"],"drugbank":["DB00416"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1743003","drugType":"Antibody","blackBoxWarning":false,"name":"CONATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 655","AMG-655","Conatumumab","TRAIL-R2 MAB","TRAIL-R2-MAB","TRAIL-R2MAB XG1-048","XG1-048"],"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","EFO_1000044","MONDO_0002158","MONDO_0015686","MONDO_0008170","EFO_0000403","EFO_1001968","EFO_0000183","EFO_1001469","EFO_0003060"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL175691","canonicalSmiles":"Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1","inchiKey":"YIBOMRUWOWDFLG-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILPIVIRINE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edurant"],"synonyms":["R 278474","R-278474","R278474","Rilpivirine","TMC-278","TMC278"],"crossReferences":{"DailyMed":["rilpivirine%20hydrochloride"],"Wikipedia":["Rilpivirine"],"drugbank":["DB08864"],"chEBI":["68606"]},"childChemblIds":["CHEMBL1628504"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL176687","canonicalSmiles":"CC1=CC(=O)NS(=O)(=O)O1","inchiKey":"YGCFIWIQZPHFLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACESULFAME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acesulfame"],"crossReferences":{"chEBI":["83501"]},"childChemblIds":["CHEMBL1351474"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1773683","canonicalSmiles":"CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1","inchiKey":"KSGCNXAZROJSNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZUTROMID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN 195","BMN-195","Ezutromid","SMT-C1100","SMTC-1100","Smt c1100"],"crossReferences":{"drugbank":["DB12888"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1788400","canonicalSmiles":"O=C(C(Cl)Cl)N(CCO)Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"ODCUSWJXZDHLKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEFAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorophenoxamide","Chlorphenoxamide","Clefamide"],"crossReferences":{"drugbank":["DB13512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180948","canonicalSmiles":"CC(C)C[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](c2cccs2)N1C(=O)c1ccc(C(F)(F)F)cc1","inchiKey":"ZNCZVHCYBGHCHA-XPIZARPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908376","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/C=C/C(O)(CC)CC)C[C@@H](O)C[C@@H]1O","inchiKey":"LVLLALCJVJNGQQ-SEODYNFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEOCALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-1089","Eb-1089","Seocalcitol"],"crossReferences":{"drugbank":["DB04258"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000182"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL19299","canonicalSmiles":"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1","inchiKey":"YMBXTVYHTMGZDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOXOPROFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loxoprofen","Loxoprofen acid","Loxoprofen sodium"],"crossReferences":{"PubChem":["144203729","170465808","50106490","85231106","90341428"],"Wikipedia":["Loxoprofen"],"drugbank":["DB09212"],"chEBI":["76172"]},"childChemblIds":["CHEMBL66552"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0002970","EFO_0000685","HP_0030833","EFO_0003898","HP_0003419","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1940832","canonicalSmiles":"O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O","inchiKey":"BMKINZUHKYLSKI-DQEYMECFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILVETEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-159797","GSK159797","Gsk159797","Milveterol","TD3327"],"childChemblIds":["CHEMBL2107356"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1951032","canonicalSmiles":"COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1","inchiKey":"WPDCHTSXOPUOII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADP-597","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adp-597","JNJ-38431055","Jnj-38431055"],"crossReferences":{"drugbank":["DB12084"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2018096","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AHFWIQIYAXSLBA-RQXATKFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1941","Ipragliflozin"],"crossReferences":{"drugbank":["DB11698"]},"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105338","canonicalSmiles":"CCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"MRWQRJMESRRJJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTIFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentifylline"],"crossReferences":{"PubChem":["170466365"],"drugbank":["DB13634"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105630","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O.Cl","inchiKey":"DFSYBWLNYPEFJK-IHLRWNDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVESPIMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL383824","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-dmag hcl","Alvespimycin hcl","Alvespimycin hydrochloride","BMS-826476","KOS-1022"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107389","canonicalSmiles":"CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"XURCMZMFZXXQDJ-UKNJCJGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTONORONE CAPROATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depostat"],"synonyms":["Gestonorone caproate","Gestonorone hexanoate","Gestronol","Gestronol hexanoate","NSC-84054","SH 582","SH-582"],"crossReferences":{"drugbank":["DB14677"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108280","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CENERSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenersen"],"linkedTargets":{"rows":["ENSG00000141510"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000222"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108774","drugType":"Unknown","blackBoxWarning":false,"name":"PLATELET CONCENTRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Platelet concentrate"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109093","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN DELTA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynepo","Dynepo (pending)"],"synonyms":["Epoetin delta","GA-EPO","HMR-4396","HMR4396"],"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109312","drugType":"Antibody","blackBoxWarning":false,"name":"MK-3415","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actoxumab","MDX-066","MK-3415","Mk-3415"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109406","drugType":"Antibody","blackBoxWarning":false,"name":"PATRITUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Patritumab"],"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003968","EFO_0005537","EFO_0004284","EFO_0000181","EFO_0003060"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2178570","canonicalSmiles":"CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1","inchiKey":"RKWKLTLIBREDHD-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD4818","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4818","AZD4818","Azd 4818","Azd-4818","Azd4818"],"linkedTargets":{"rows":["ENSG00000163823"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2218896","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21","inchiKey":"GECBBEABIDMGGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NABILONE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cesamet"],"synonyms":["CPD 109514","CPD-109514","Nabilone"],"crossReferences":{"DailyMed":["nabilone"]},"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0001257","EFO_0004320","EFO_0005687","EFO_0001073","HP_0002018","EFO_0000311","EFO_0007191","EFO_1000783","MONDO_0005301","HP_0009763","MONDO_0005180","EFO_0003100","HP_0002017","EFO_0004888","EFO_0004242"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL2364632","canonicalSmiles":"CON(C)Cc1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"PQJQFLNBMSCUSH-SBAJWEJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARECYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["P-005672","P005672","Sarecycline"],"crossReferences":{"DailyMed":["sarecycline%20hydrochloride"],"drugbank":["DB12035"]},"childChemblIds":["CHEMBL2364633"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2369994","canonicalSmiles":"CC(=O)NCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O.O=C(O)C(F)(F)F","inchiKey":"PNJSAKBBGRRTHL-RBUYSXEJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TIGAPOTIDE TRIFLUTATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3040192","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PCK3145","Tigapotide triflutate"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2426701","canonicalSmiles":"CC1=CC(=O)[C@H]2C[C@@H]1C2(C)C","inchiKey":"DCSCXTJOXBUFGB-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOVERBENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-verbenone","(1s)-(-)-cis-verbenone","(1s)-(-)-verbenone","(s)-verbenone","L-verbenone","Laevo-verbenone","Levoverbenone","NSC-6831","Verbenone, (-)-","Verbenone, (1s)-"],"crossReferences":{"PubChem":["144211748"],"drugbank":["DB13391"],"chEBI":["78316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253363","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"ORNBQBCIOKFOEO-QGVNFLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGNENOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pregnenolone"],"crossReferences":{"PubChem":["144205564","144212458","170465558","26756472","29216415","56463239"],"Wikipedia":["Pregnenolone"],"drugbank":["DB02789"],"chEBI":["16581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255696","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO","inchiKey":"VBICKXHEKHSIBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL MONOSTEARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Eastman 600"],"synonyms":["Cerasynt sd","Cerasynt-sd","Cithrol gms 0400","Cremophor gmsk","Cutina gms","FEMA NO. 2527","Glycerides, c16-18 mono-","Glycerol monostearate","Glycerol stearate","Glyceroli monostearas","Glyceryl monopalmitostearate","Glyceryl monostearate","Glyceryl stearate","Imwitor 491","Lonzest gms","Monoglycerides, c16-18","Monostearin","Nikkol mgs-a","Sorbon mg-100","Stearin","Stearin, mono-"],"crossReferences":{"PubChem":["144205713","144209771","144211421","170465522","26757948"],"Wikipedia":["Glycerol_monostearate"],"drugbank":["DB11250"],"chEBI":["75555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257543","canonicalSmiles":"N#Cc1ccc(NCC(F)(F)c2ccccn2)c(F)c1CC(=O)NCCONC(=N)N","inchiKey":"STHCHQXQLDMISY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277945","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC","inchiKey":"UNRHXEPDKXPRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sultopride","Sultopride hydrochloride"],"crossReferences":{"Wikipedia":["Sultopride"],"drugbank":["DB13273"],"chEBI":["9356"]},"childChemblIds":["CHEMBL3182384"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL279229","canonicalSmiles":"COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1","inchiKey":"ICMGLRUYEQNHPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URAPIDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ebrantil","NSC-310405","Urapidil"],"crossReferences":{"PubChem":["104171260","11111935","11111936","11114211","144203849","26752246","90341686","99361071"],"Wikipedia":["Urapidil"],"drugbank":["DB12661"]},"childChemblIds":["CHEMBL1256716"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL282199","canonicalSmiles":"CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1","inchiKey":"HWKROQUZSKPIKQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-269970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-269970"],"crossReferences":{"PubChem":["11114150","50104910"],"Wikipedia":["SB-269,970"],"drugbank":["DB13988"]},"childChemblIds":["CHEMBL1256844"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284121","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"JKFZMIQMKFWJAY-RQJQXFIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILX23-7553","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BXL 353","BXL-353","ILEX-23-7553","ILX-23-7553","ILX-237553","ILX7553","Ilx 237553","Ilx23-7553","Ro-23-7553"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183067","canonicalSmiles":"CC(=O)OC(C)OC(=O)C(C)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"ALIVXCSEERJYHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183067","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206486","144206574"],"drugbank":["DB14938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328875","canonicalSmiles":"NCc1ccc(C(=O)O)cc1","inchiKey":"QCTBMLYLENLHLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOMETHYLBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(Aminomethyl)Benzoic Acid","4-Aminomethyl-Benzoic Acid","Aminomethylbenzoic acid"],"crossReferences":{"PubChem":["4252934","96420"],"Wikipedia":["Aminomethylbenzoic_acid"],"drugbank":["DB13244"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301571","drugType":"Cell","blackBoxWarning":false,"name":"VESIGENURTUCEL-L","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-410","UM-UC-3-gp96-Ig-HLA-A1","Vesigenurtucel-l"],"description":"Cell drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL330829","canonicalSmiles":"CCOC(=O)/C=C1\\SC(N2CCCCC2)C(=O)N1C","inchiKey":"ZCKKHYXUQFTBIK-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOZOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elkapin","Etozolin","GO-687","GO-787","NSC-310039","W 2900A","W-2900A"],"crossReferences":{"drugbank":["DB08982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3338194","canonicalSmiles":"CS(=O)(=O)c1ccc(-n2cc(Cl)c(OC3CCN(c4ncc(Cl)cn4)CC3)cc2=O)c(F)c1","inchiKey":"OGIAVRWXUPYGGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-903452","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-903452"],"crossReferences":{"drugbank":["DB11773"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL334167","canonicalSmiles":"Cn1sc(=O)c2cc(S(N)(=O)=O)ccc21","inchiKey":"DFPYCCVFXMWMJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL334167","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03294"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL349605","canonicalSmiles":"OC[C@H](O)[C@H](O)CO","inchiKey":"UNXHWFMMPAWVPI-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E968"],"crossReferences":{"PubChem":["144207762","57260106"],"Wikipedia":["Erythritol"],"drugbank":["DB04481"],"chEBI":["17113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545050","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-817378","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-817378"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545106","drugType":"Protein","blackBoxWarning":false,"name":"TM30339","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tm30339"],"linkedTargets":{"rows":["ENSG00000204174"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545113","drugType":"Small molecule","blackBoxWarning":false,"name":"PX-102","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Px-102","Px-104"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_0003095"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545200","drugType":"Small molecule","blackBoxWarning":false,"name":"S-222611","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-222611"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545259","drugType":"Antibody","blackBoxWarning":false,"name":"VANUCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C0u97738ae","RG-7221","RG7221","RO-5520985","RO5520985","Vanucizumab"],"linkedTargets":{"rows":["ENSG00000091879","ENSG00000112715"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707260","canonicalSmiles":"Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Na+].[Na+]","inchiKey":"FSDMNNPYPVJNAT-RIWFDJIXSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FOLINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1679","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disodium folinate","Folinic acid disodium","Leucovorin sodium","Oncofolic","Sodium folinate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707315","drugType":"Small molecule","blackBoxWarning":false,"name":"D-3263","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 3263","D-3263","D-3263 (FREE BASE)"],"linkedTargets":{"rows":["ENSG00000144481"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833321","drugType":"Antibody","blackBoxWarning":false,"name":"LECANEMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAN-2401","BAN2401","Ban 2401","Ban2401","Lecanemab"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL383990","canonicalSmiles":"c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1","inchiKey":"JTKFRFMSUBOCIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383990","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3936761","canonicalSmiles":"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1","inchiKey":"RNOAOAWBMHREKO-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANUBRUTINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brukinsa"],"synonyms":["BGB-3111","Bgb-3111","Zanubrutinib"],"crossReferences":{"DailyMed":["zanubrutinib"],"drugbank":["DB15035"]},"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0005761","EFO_0000403","EFO_1000157","EFO_1001469","EFO_0000311","EFO_0000565","EFO_0007160","MONDO_0100096","EFO_0000096","EFO_0000095","MONDO_0017287","EFO_0000574","MONDO_0018906","MONDO_0015564","MONDO_0002083"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for mantle cell lymphoma and has 12 investigational indications."}
{"id":"CHEMBL3989402","canonicalSmiles":"CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N.O.O.O","inchiKey":"RFUCJKFZFXNIGB-ZBBHRWOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAMIVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139367","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapivab"],"synonyms":["BCX-1812","Peramivir","Peramivir hydrate","Peramivir trihydrate","Rapiacta"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for influenza."}
{"id":"CHEMBL3989444","canonicalSmiles":"CC[C@@H](C)C(=O)O[C@@H]1[C@H](OC(C)=O)c2c(ccc3ccc(=O)oc23)OC1(C)C","inchiKey":"GVBNSPFBYXGREE-CXWAGAITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VISNADINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Visnadin","Visnadine"],"crossReferences":{"drugbank":["DB13355"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989754","canonicalSmiles":"CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+]","inchiKey":"GNMBMOULKUXEQF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURBIPROFEN SODIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL563","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansaid","Flurbiprofen sodium","Occufen","Ocufen","Zepolas"],"synonyms":["Flurbiprofen sodium","Flurbiprofen sodium anhydrous","Flurbiprofen sodium dihydrate"],"crossReferences":{"DailyMed":["flurbiprofen%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL3989945","canonicalSmiles":"CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](OCC[N+](C)(C)C)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1","inchiKey":"LNFCWEXGZIEGJW-TXSVMFMRSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"REZAFUNGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biafungin","CD-101","CD101","Rezafungin","Rezafungin cation","Rezafungin ion","SP-3025"],"childChemblIds":["CHEMBL3989928"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL409","canonicalSmiles":"CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"LKJPYSCBVHEWIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICALUTAMIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicalutamide","Calutide","Casodex","Cosudex","Kalumid"],"synonyms":["Bicalutamide","Casodex","ICI 176,334","ICI-176334","ICI176,334-1","NSC-759816"],"crossReferences":{"DailyMed":["bicalutamide"],"PubChem":["26719836"],"drugbank":["DB01128"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000616","EFO_0003869","MONDO_0008170","MONDO_0007254","MONDO_0004669","EFO_0000313","MONDO_0002087","HP_0000771","MONDO_0008315","EFO_0000305","EFO_0001663","MONDO_0002158","MONDO_0100096","MONDO_0000088","EFO_0000673","EFO_0000196"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for neoplasm and carcinoma and has 15 investigational indications."}
{"id":"CHEMBL419186","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OCCN","inchiKey":"IBTISPLPBBHVSU-UVOOVGFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL419186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297339","drugType":"Protein","blackBoxWarning":false,"name":"COPPER OXODOTREOTIDE CU-64","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4302413","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Detectnet"],"synonyms":["64cu-dotatate","Copper 64-dota-tate","Copper cu-64 dotatate","Copper dotatate cu-64","Copper oxodotreotide cu-64"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for neuroendocrine neoplasm."}
{"id":"CHEMBL4297550","drugType":"Unknown","blackBoxWarning":false,"name":"ATYR-1940","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atyr-1940","Atyr1940","Hars (residues 2-506)","Resolaris"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297585","canonicalSmiles":"CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC","inchiKey":"PJHKBYALYHRYSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEPTANOIN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dojolvi"],"synonyms":["Dermofeel tc 7","Dermofeel tc-7","Dub thg","Heptanoin, tri-","Lanol 37 t","Radiamuls 2375","Trienanthoin","Triheptanoic glyceride","Triheptanoin","Trioenanthoin","UX-007","UX007","Ux007"],"crossReferences":{"DailyMed":["triheptanoin"],"drugbank":["DB11677"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 9 investigational indications."}
{"id":"CHEMBL4297846","drugType":"Unknown","blackBoxWarning":false,"name":"UB-421","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Db4c7 mab","Mab db4c7","UB-421","UB-421 (DB4C7 MAB)","UB421","Ub-421"],"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000544","EFO_0000180"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4301600","canonicalSmiles":"CC(C)(O)c1cccn2c(C3(c4ccc(Cl)cc4)CC3)nnc12","inchiKey":"PTIFVLOBVCIMKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-823778","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297457"],"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","MONDO_0005148","Orphanet_309005","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL434","canonicalSmiles":"CC(C)NCC(O)c1ccc(O)c(O)c1","inchiKey":"JWZZKOKVBUJMES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROTERENOL","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-21","Aleudrin","Aludrine","Asiprenol","Asmalar","Assiprenol","Bellasthman","Isonorin","Isoprenaline","Isopropydrin","Isoproterenol","Isoproterenol dl-form","Isorenin","Isupren","NSC-33791","NSC-9975","Neo-epinine","Neodrenal","Novodrin","Proternol","Respifral","Saventrine","Vapo-n-iso"],"crossReferences":{"DailyMed":["isoproterenol%20hydrochloride"],"PubChem":["104171176","144203723","170464679","26752240","50104946","50111114","90340610"],"Wikipedia":["Isoprenaline"],"drugbank":["DB01064"],"chEBI":["64317"]},"childChemblIds":["CHEMBL3989521","CHEMBL1711"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0000759","HP_0006536","EFO_0000275","Orphanet_230","EFO_0004253","EFO_1000645","EFO_0005252","EFO_0000373","EFO_0000319","EFO_0001073"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL44083","canonicalSmiles":"CCNCCCNCCCNCCCNCC","inchiKey":"UMJJGDUYVQCBMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIS(ETHYL)NORSPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113515"],"drugbank":["DB06445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445420","canonicalSmiles":"O=C(Nc1ccccc1)c1cc[nH]n1","inchiKey":"WMZYZYFPPQOFKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14738661"],"drugbank":["DB08135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446785","canonicalSmiles":"CC(/C=C/C=C(\\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C\\C=C\\C=C(C)\\C=C\\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SEBIKDIMAPSUBY-RTJKDTQDSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"CROCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-crocin","Crocetin Di(Beta-Gentiobiosyl)Ester","Crocetin di-gentiobiose ester","Crocin","Crocin 1"],"crossReferences":{"PubChem":["144205390","29216153"],"drugbank":["DB11874"],"chEBI":["79068"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL447878","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OVRNDRQMDRJTHS-FMDGEEDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-ACETYLGLUCOSAMINE ","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Acetyl Glucosamine","N-acetylglucosamine "],"crossReferences":{"Wikipedia":["N-Acetylglucosamine"],"chEBI":["28009"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL452329","canonicalSmiles":"CC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C","inchiKey":"IVCRCPJOLWECJU-XQVQQVTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRESTOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-142229","NSC-69948","Trestolone","Trestolone acetate","U-15,614","U-15614"],"crossReferences":{"drugbank":["DB13958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4571518","canonicalSmiles":"O=c1[nH]c(NCc2ccc(Cl)c(Cl)c2)nc2ncn(CCN3CCOCC3)c12","inchiKey":"DEGSGBKTODESHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBEZAPOLSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACX-362E","Acx-362e","Ibezapolstat"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594254","canonicalSmiles":"C(=C/[C@H]1CCNC1)\\c1cncnc1","inchiKey":"FNEHSHNEXMPCLJ-VWCDRPFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMPINICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OC-02","Oc-02","Simpinicline","TC-6499","TC-6499-12","TC6499","Tc-6499"],"childChemblIds":["CHEMBL4594377"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204","ENSG00000117971","ENSG00000080644"],"count":4},"linkedDiseases":{"rows":["EFO_0000555","EFO_1000906","EFO_1000948"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650262","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"LEXANERSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMTR-5149 FREE ACID","BMTR5149","BMTR5149 FREE ACID","Lexanersen","WV-2603 FREE ACID","WV2603","WVE-120102","WVE-120102 FREE ACID","Wve-120102"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650501","drugType":"Unknown","blackBoxWarning":false,"name":"PF-4136309","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-8761","INCB8761","PF-04136309","PF-4136309","Pf-04136309","Pf-4136309"],"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003860","EFO_0002517","EFO_0004616"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650626","drugType":"Small molecule","blackBoxWarning":false,"name":"YTTRIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650364"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL477487","canonicalSmiles":"Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](COP(=O)(O)O)O3)c2n1","inchiKey":"LTFMZDNNPPEQNG-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Deoxyguanosine 5'-Monophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxyguanosine 5'-Monophosphate"],"crossReferences":{"drugbank":["DB04457"],"chEBI":["16192"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480","canonicalSmiles":"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1","inchiKey":"MJIHNNLFOKEZEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANSOPRAZOLE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lansoprazole","Opiren","Prevacid","Prevacid 24 hr","Prevacid Delayed Release","Prevacid Solutab","Prevacid iv","Zoton"],"synonyms":["A-65006","AG-1749","Agopton","Lansoprazole","Lansox","Lanzoprazole","Lanzor","Limpidex","NSC-758638","Ogast","Ogastoro","Prevonco","Takepron"],"crossReferences":{"DailyMed":["lansoprazole"],"PubChem":["11111389","11111390","124880589","124880592","144203735","144211340","170464649","174007196","26719660","26747053","50104195","50104197","56422192","57287635","85231117","855954","90341606"],"Wikipedia":["Lansoprazole"],"drugbank":["DB00448"],"chEBI":["6375"]},"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["HP_0001600","HP_0002239","EFO_0000768","EFO_0004274","EFO_1000657","MONDO_0007254","Orphanet_586","EFO_1001461","EFO_0003948","HP_0004398","MONDO_0002974","EFO_1000961","EFO_0003917","EFO_0000616","EFO_0009686","EFO_0000280","EFO_0000217","EFO_0004269","EFO_0004607","EFO_0003843","EFO_1001355","EFO_0008533","EFO_0004232","EFO_0009454","EFO_0000095","Orphanet_758","MONDO_0005147","MONDO_0011962","EFO_0000574","MONDO_0004979","EFO_0007456","MONDO_0005178","EFO_1000270","EFO_1001095","EFO_0007415"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 21 investigational indications."}
{"id":"CHEMBL490867","canonicalSmiles":"COc1ccc(OC)c2c1c(C)cc(=O)n2C","inchiKey":"FTGZPMFPUDKJBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490867","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL502384","canonicalSmiles":"C1CN1c1nc(N2CC2)nc(N2CC2)n1","inchiKey":"IUCJMVBFZDHPDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIETHYLENEMELAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-9706","Tretamine","Triethylene melamine","Triethylenemelamine"],"crossReferences":{"PubChem":["75085"],"Wikipedia":["Triethylenemelamine"],"drugbank":["DB14031"],"chEBI":["27919"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL549343","canonicalSmiles":"CNCc1ccccc1-c1cccs1","inchiKey":"MRKJJEJYTBOUTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549343","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07196"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL587723","canonicalSmiles":"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1","inchiKey":"OONFNUWBHFSNBT-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AEE-788","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEE-788","AEE788","Aee 788","Aee-788","GNF-PF-5343","NVP-AEE-788","NVP-AEE788"],"crossReferences":{"Wikipedia":["AEE788"],"drugbank":["DB12558"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000128052","ENSG00000102755","ENSG00000141736"],"count":4},"linkedDiseases":{"rows":["EFO_0000519","EFO_1000158","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL639","canonicalSmiles":"CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1","inchiKey":"MBUVEWMHONZEQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELASTINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Azelastine","NSC-758971"],"crossReferences":{"DailyMed":["azelastine%20hydrochloride"],"Wikipedia":["Azelastine"],"drugbank":["DB00972"],"chEBI":["2950"]},"childChemblIds":["CHEMBL1200809"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0009364","EFO_0007533","MONDO_0005271","EFO_0007141","EFO_0005751","EFO_1001417","HP_0001742","EFO_0003956"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 8 approved and 4 investigational indications."}
{"id":"CHEMBL67776","canonicalSmiles":"CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C","inchiKey":"DIKSYHCCYVYKRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAQUINIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABR-215757","Paquinimod"],"crossReferences":{"drugbank":["DB13118"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL717","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"PSGAAPLEWMOORI-PEINSRQWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEDROXYPROGESTERONE ACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adgyn medro","Amen","Climanor","Curretab","Cycrin","Depo-progevera","Depo-provera","Depo-provera oncology","Depo-subq provera 104","Farlutal","Farlutal 100","Farlutal 200","Farlutal 250","Farlutal 500","Lunelle","Medroxyprogesterone acetate","Provera","Sayana press"],"synonyms":["Amen","Farlutal inyectable","G03AC06","Medroxiprogesterone acetate","Medroxyprogesterone","Medroxyprogesterone 17-acetate","Medroxyprogesterone Acetate","Medroxyprogesterone acetate","Medroxyprogesteroni acetas","NSC-21171","NSC-26386","NSC-27408","Prempro","Provera","TV-46046"],"crossReferences":{"DailyMed":["medroxyprogesterone%20acetate"],"PubChem":["144204872","144207339","170464622","17388931","26751478","56422500","855664"],"Wikipedia":["Medroxyprogesterone_acetate"],"drugbank":["DB00603"],"chEBI":["6716"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001065","EFO_0007453","EFO_0000681","EFO_0004230","HP_0031217","HP_0000132","EFO_0002890","EFO_0003882","EFO_0002950","MONDO_0041161","EFO_1001375","EFO_0002690","HP_0008209","EFO_0000673","EFO_0000400","EFO_0003877","EFO_0000198","EFO_0000616","EFO_0000545","HP_0003124","EFO_0001645","EFO_0000180","EFO_0000319","EFO_0000536","EFO_0003843","EFO_0000537","MP_0001914","MONDO_0000831","EFO_0000764","MONDO_0011962","MONDO_0004975","MONDO_0002367","Orphanet_881","EFO_0003922","EFO_1000233"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 6 approved and 25 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL73962","canonicalSmiles":"NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccccc2)s1","inchiKey":"PWDGTQXZLNDOKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzolamide"],"crossReferences":{"drugbank":["DB07050"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL961","canonicalSmiles":"CCN(CC)C(=S)S","inchiKey":"LMBWSYZSUOEYSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITIOCARB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbamic acid, diethyldithio-","Carbamodithioic acid, diethyl-","Diethyl dithiocarbamate","Diethyldithiocarbamate"],"crossReferences":{"PubChem":["29218086"],"drugbank":["DB02520"]},"childChemblIds":["CHEMBL3185333","CHEMBL107217","CHEMBL3182813"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL983","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]","inchiKey":"YOEWQQVKRJEPAE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"SUCCINYLCHOLINE CHLORIDE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL703","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anectine","Quelicin","Quelicin preservative free","Scoline","Succinylcholine chloride","Sucostrin","Suxamethonium Chloride"],"synonyms":["Choline chloride succinate (2:1)","NSC-49132","Succinylcholine chloride","Suxamethone","Suxamethonii chloridum","Suxamethonium chloride","Suxamethonium chloride dihydrate","Suxamethonium chloride hydrate"],"crossReferences":{"DailyMed":["succinylcholine%20chloride"],"PubChem":["144204820","170464625","50106980"],"Wikipedia":["Suxamethonium_chloride"],"chEBI":["61219"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0002950"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1952. This drug has a black box warning from the FDA."}
